Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer

Circulating Tumor DNA as a Prognostic Biomarker in Localized Non-small Cell Lung Cancer

BackgroundRoutine clinical surveillance involves serial radiographic imaging following radical surgery in localized non-small cell lung cancer (NSCLC). However, such surveillance can detect only macroscopic disease recurrence and is frequently inconclusive. We investigated if detection of ctDNA befo...

Full description

Bibliographic Details
Main Authors: Muyun Peng, Qi Huang, Wei Yin, Sichuang Tan, Chen Chen, Wenliang Liu, Jingqun Tang, Xiang Wang, Bingyu Zhang, Min Zou, Jina Li, Wenhui Su, Lientu Wang, Lihan Chin, Fenglei Yu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
circulating tumor DNA
circulating single molecule amplification and re-sequencing technology
prognostic biomarker
minimal residual disease
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.561598/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.561598/full

Similar Items